TriSalus Life Sciences appoints Steven Katz as chief medical officer
DENVER -- TriSalus Life Sciences announced the appointment of Steven Katz , M.D., as its chief medical officer. Katz will oversee the company’s clinical development strategy as it seeks to... Read More
Monday October 5, 2020
TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate
DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More
Monday September 28, 2020
TriSalus Life Sciences appoints Scott Davie chief technology officer
DENVER -- TriSalus Life Sciences announced the appointment of Scott Davie to the role of chief technology officer, deepening the company’s leadership capabilities as it builds an integrated... Read More
Monday June 8, 2020
TriSalus Life Sciences launches TriNav Infusion System to overcome infusion barriers in tumors
DENVER -- TriSalus Life Sciences announced the launch of its TriNav Infusion System. Powered by its proprietary Pressure-Enabled Drug DeliveryTM (PEDD) approach with SmartValveTM technology,... Read More
Thursday January 16, 2020
TriSalus Life Science’s drug delivery shows efficacy against pancreatic cancer
WESTMINSTER -- A phase 1b clinical trial shows that administering a concentrated dose of anti-CEA CAR-T cells precisely at the site of a solid tumor by means of TriSalusLife Sciences unique... Read More
Wednesday November 7, 2018
TriSalus Life Sciences names Daniel Estay chief business officer
DENVER -- TriSalus Life Sciences announced the appointment of Daniel Estay as its chief business officer, reporting to the companys chief executive officer, Mary Szela . TriSalus (formerly... Read More
Monday September 24, 2018
IN Sponsors
Browse
Entrepreneurial by Nature
